Home / Compounds / Mitragynine Pseudoindoxyl / District of Columbia

Is Mitragynine Pseudoindoxyl Legal in District of Columbia? (2026)

Illegal

As of September 23, 2026, Mitragynine Pseudoindoxyl is illegal to sell (federally scheduled; state law on file reads legal) in District of Columbia. Pseudoindoxyl -- federally Schedule I (DEA temporary order, drug code 9672, eff. 2026-08-26). Controlling source: 22-B DCMR 1201 Schedule I Enumerated (Department of Health), as amended effective 12/2/2016 - proof of absence for mitragynine / Mitragyna, 1201.1(h)(16).

Verified September 23, 2026 (manual) · confidence: confirmed
Federal
Pseudoindoxyl -- federally Schedule I (DEA temporary order, drug code 9672, eff. 2026-08-26) (effective 2026-08-26). State-law reading underneath: Legal.
Rule type
permanent
Tier
unscheduled

Controlling language, verbatim

D.C. Code Sec. 48-902.04 Schedule I does not list mitragynine, 7-hydroxymitragynine, mitragynine pseudoindoxyl, or speciociliatine; no analogue catch-all reaches them; DC has no Kratom Consumer Protection Act.

Source of excerpt

Citations

  1. 22-B DCMR 1201 Schedule I Enumerated (Department of Health), as amended effective 12/2/2016 - proof of absence for mitragynine / Mitragyna, 1201.1(h)(16) (DC Office of Documents and Administrative Issuances (DCRegs), 2026-09-22) PRIMARYOFFICIAL

Change history

  • Headline updated: "Not listed in DC Schedule I: neither D.C. Code 48-902.04 nor 22-B DCMR 1201 names mitragynine or Mitragyna speciosa (the 2016 DC rule scheduled 7-hydroxymitragynine only)".

Where Mitragynine Pseudoindoxyl stands across the country

LegalRestrictedGray areaIllegalNot yet verified

Among District of Columbia's 2 neighbors, Maryland and Virginia are illegal, the same posture as District of Columbia.

Open the interactive map · Every compound in District of Columbia

Federal posture

Federally scheduled or prohibited. Pseudoindoxyl -- federally Schedule I (DEA temporary order, drug code 9672, eff. 2026-08-26) Federal detail

Pending deadlines

  • 2026-08-01 · Federal · DEA temporary Schedule I order for mitragynine pseudoindoxyl, MGM-15, MGM-16 - effective on Federal Register publication (DEA NOI 2026-07-01)
  • 2026-08-05 · Federal · DEA temporary Schedule I - mitragynine pseudoindoxyl, MGM-15, MGM-16 (DEA-1644 / FR 2026-17429)
    Second DEA Notice of Intent filed with the Federal Register on 7/1/2026 (companion to the 7-OH NOI, DEA-1570), placing three 7-OH-RELATED substances — mitragynine pseudoindoxyl (MP), MGM-15, and MGM-16 — into Schedule I under 21 U.S.C. 811(h). HHS confirmed these have no accepted medical use and a high potential for abuse. Same procedural clock as the 7-OH NOI: 30-day notice period, temporary order cannot issue before ~2026-08-05, effective on Federal Register publication of the order, 2-year duration (+1 yr possible). Unlike the 7-OH NOI there is NO concentration threshold here — these named substances are controlled outright. Confirm the exact companion docket number when the Federal Register posts on 7/6/2026.
  • 2026-11-13 · Federal · DEA to replace pseudoindoxyl Schedule I order with a threshold order (re-notice) (DEA-1570 / FR 2026-20943)
    On or after Nov 13, 2026 DEA intends to withdraw the Aug 26 order (FR 2026-17429) and place pseudoindoxyl in Schedule I only above a threshold: more than 1 mg/g or 1 mg/mL alone or combined with 7-OH, or mitragynine under 100 times the pseudoindoxyl or combined amount. Until then it stays Schedule I at any amount. MGM-15 and MGM-16 stay Schedule I unchanged (FR 2026-20942).

Verbatim law on file for District of Columbia

1 instrument on file for this compound's framework in District of Columbia; 1 of 1 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.

D.C. Official Code Sec. 48-902.04 (Schedule I) - proof of absence · DC Schedule I - kratom/7-OH/pseudoindoxyl/speciociliatine ABSENT (all legal)OFFICIAL
Instrument
DC Schedule I - kratom/7-OH/pseudoindoxyl/speciociliatine ABSENT (all legal)
Source
https://code.dccouncil.gov/us/dc/council/code/sections/48-902.04
Retrieved
2026-07-07
Fingerprint
0a308e4df4f17b4e
D.C. Official Code Sec. 48-902.04 (Schedule I enumerated). Opiate class (1) is a closed NAMED list ("any of the following opiates, including their isomers, esters, ethers, salts...") that does NOT include mitragynine, 7-hydroxymitragynine, mitragynine pseudoindoxyl, or speciociliatine. Hallucinogen class (3) ("any material...which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers...") runs alphabetically ...Lysergic acid diethylamide; Methoxetamine; Mescaline; Peyote... with NO "Mitragynine" entry at the M slot. DC Schedule I has NO general controlled-substance-analogue catch-all (only Synthetic Cathinones = 2-amino-1-propanone structures, and Synthetic Cannabimimetic Agents = cannabinoid-receptor agonists, neither of which reaches indole alkaloids). A full-text search of Sec. 48-902.04 for mitragynine / kratom / 7-hydroxy / pseudoindoxyl / speciociliatine returns ZERO matches. DC has enacted no Kratom Consumer Protection Act.

Related

Mitragynine Pseudoindoxyl in neighboring states

Mitragynine Pseudoindoxyl in other states

Same framework in District of Columbia

Other compounds in District of Columbia

Cite this page

Compound Analytics. "Is Mitragynine Pseudoindoxyl Legal in District of Columbia? (2026)." Compound Laws, https://compoundlaws.com/compounds/pseudoindoxyl/district-of-columbia/. Accessed October 25, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap